Covid-19, Coronavirus Clinical Trials Worldwide
With the pandemic of Covid-19 continuing across the globe, pharmaceutical companies, scientists, hospitals and health care organizations around the world continue to accelerate clinical research to find a treatment and possible vaccine.
The number of Covid-19, coronavirus clinical trials has been steadily growing since January 2020. As of March 31st, there are 287 active Clinical Trials around the world focused on Covid-19.
These Clinical Trials are being conducted across most regions of the world; Europe has 100 going on, Asia has 79 and North America has 56. Within each of these regions we can also find the number of Covid-19 Clinical Trials by Country.
We expect further growth over the next few months in the number of Clinical Trials for Covid-19 around the world. We will publish any updates as data of new Clinical Trials are made available.
We are actively consulting on how to successfully fast-track market access of health product developed for addressing the current pandemic. Communicate with us to see how we can help.
Download a Covid-19 Clinical Trial summary report
We have co-published a report on Covid-19 Clinical Trials with our friends at the Clinical Research Organization, McDougall Scientific. We have taken clinical trial data directly from clinicaltrials.gov provided by the National Institutes of Health and published a summary of the data in a format that is hopefully useful to digest.
Some of the data provided includes:
- # of Covid-19 Clinical Trials by Country
- # of Covid-19 Clinical Trials by Sponsors/Collaborators
- # of Covid-19 Clinical Trial by Drug Interventions
- # of Covid-19 Clinical Trials that have been completed
With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.
Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.